Equity issuance and dilution question

I understand that you are in a way diluting current shareholders when you raise additional equity (assuming company is already public) because you now have lower eps and you have cut the pie into more pieces. My question relates to how the capital raised plays into this equation, as I feel like when people talk about dilution they brush over the cash the company just raised. Thanks in advance.

14 Comments
 

Cash goes to the balance sheet so if you were just to raise Equity to sit on some cash it'd be the most dilutive because that cash isn't used to generate any earnings (more cash doesn't mean net earnings goes up). and just make things more clear, eps is price per share/earnings per share which is equivalent to market cap / net income. So in this case, your market cap went up but your net income stayed the same

 
jzhang0368Cash goes to the balance sheet so if you were just to raise Equity to sit on some cash it'd be the most dilutive because that cash isn't used to generate any earnings (more cash doesn't mean net earnings goes up). and just make things more clear, eps is price per share/earnings per share which is equivalent to market cap / net income. So in this case, your market cap went up but your net income stayed the same

EPS is earnings per share = Net Income/#Shares outstanding

Fear is the greatest motivator. Motivation is what it takes to find profit.
 

Thanks for the response. One of my original questions/points was that I feel that the new cash on their balance sheets adds value as it can be used to purchase assets and increase earnings. Also, theoretically should the stock price adjust so that market cap remains unchanged? Or does market cap increase as E=A-L, and assets and thus equity rises by the cash raised.

Edit: I think I get it now. You are simple reorganizing the capital structure. Equity value rises, cash rises, thus lowing net debt by the amount of the rise in equity value, leaving enterprise value unchanged. And as you pointed out same earnings over more shares=dilution.

 

You have the right idea. Most of the time when a company does an equity deal the use of proceeds will be 'general corporate purposes' so its inherently dilutive because you can't make a far stretched assumption that the new cash will be used efficiently to boost earnings. However, in some instances where there is a clearly defined UOP (ie an acquisition), the company selling equity will try to illustrate how the raise will be used to fund a transaction that will be accretive down the road.

 
Best Response

Ok, so it seems like there is a bit of a contradiction in the case in which a company doesn't detail how an equity raise will boost earnings. It seems as though on one extreme earnings forecasts remain unchanged, thus EPS diminishes, thus share price should come down so that market cap is the same as it was before the issuance (in theory, this would leave mkt cap unchanged, lower net debt, and lower firm value). The flip side is that the company issues shares at the pre-issuance market price and the share price doesn't fall which raises mkt cap and lowers net debt by the amount raised, leaving firm value unchanged. Is the reality usually somewhere in between, where the cash is given some discounted value, so share price falls but mkt cap still rises (but by less than the proceeds of the issuance)? Also, as a shareholder is there a situation in which an equity raise will potentially be viewed as a positive apart from an accretive acquisition opportunity or an issuance at a premium to NAV/share. Lastly, what is a situation in which an accretive acquisition is not viewed favorably (I've read that the accretion/dilution of a transaction doesn't tell the whole story)? Thanks!

 

my 2 cents:

1) "It seems as though on one extreme earnings forecasts remain unchanged, thus EPS diminishes, thus share price should come down so that market cap is the same as it was before the issuance (in theory, this would leave mkt cap unchanged, lower net debt, and lower firm value)"

This analysis is flawed: while EPS does diminish share price does not necessarily go down, unless you're under the assumption that p/e is constant which has no basis. In theory what happens is your mkt cap goes up net debt goes down by the same amount and firm value unchanged. Why would the firm value change if you're just putting cash (even if it's just sitting there) on a firm's balance sheet?

In reality though followons are almost always at a discount due to many reasons and has been a major topic in academia. Just google it and you'll find plenty of explanations.

2) "Also, as a shareholder is there a situation in which an equity raise will potentially be viewed as a positive apart from an Accretive acquisition opportunity or an issuance at a premium to NAV/share"

If the UOP is for sth really profitable and NPV positive then in theory it can be viewed as positive. In reality if there's was such an opp then market woulda priced it in b4 the raising already.

3) "Lastly, what is a situation in which an Accretive acquisition is not viewed favorably (I've read that the accretion/dilution of a transaction doesn't tell the whole story)?"

If the target's earnings is projected to be flat until the end of time (a bit extreme but you get the idea)

 

This is what I take away when reading this.

Typically, you'd want to raise a certain dollar amount and not necessarily target a # of shares issued. If you want to raise $1 Bn, he number of shares you have to issue = 1Bn/Price per Share. If your denominator was recently halved, you can guess what that means for number of shares required to be issued (and the resultant diluting effect).

Director of Finance and Corporate Development: 2020 - Present Manager of FP&A and Corporate Development: 2019 - 2020 Corporate Finance, Strategy and Development: 2011 - 2019 "An investment in knowledge pays the best interest." - Benjamin Franklin
 

Placeat odit debitis inventore minima illum quis. Impedit laudantium sunt magnam rerum. Sed incidunt explicabo omnis.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (72) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”